Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00787085 · ClinicalTrials.gov registry record
The Significance of Funguria in Hospitalized Patients
A clinical trial of Urinary Tract Infections, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- Completed
- Registry status
- 919
- Enrollment target
- 2
- Study locations
NCT00787085 is a study of Urinary Tract Infections that has completed, run by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The registered enrollment target is 919 participants, above the 431-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (113% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT00787085, a study of Urinary Tract Infections, has completed, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- COMPLETED
- Registry status
- 919 participants
- Enrollment target
- 2
- Study locations
Study Summary
This investigation is a epidemiologic case-control study of the risk factors associated with nosocomial funguria (fungi in the urine).
Conditions Studied
Study Locations (2)
California
- Cedars-Sinai Medical Center - Los Angeles
- Harbor-UCLA Medical Center - Torrance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 919 participants |
| Start Date | 2001-09 |
| Est. Completion | 2006-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00787085
The ClinicalTrials.gov registry entry for NCT00787085 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 919 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 431-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (113% higher). The listed sponsor is Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Urinary Tract Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00787085 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00787085 about?
NCT00787085 is a clinical study titled "The Significance of Funguria in Hospitalized Patients". This investigation is a epidemiologic case-control study of the risk factors associated with nosocomial funguria (fungi in the urine).
What is the current status of trial NCT00787085?
This trial is currently completed. The enrollment target is 919 participants. The study started on 2001-09. Estimated completion is 2006-02.
What conditions does trial NCT00787085 study?
This clinical trial studies the following conditions: Urinary Tract Infections.
Who is sponsoring clinical trial NCT00787085?
This trial is sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00787085 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
RECRUITING · Phase 1
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
RECRUITING · NA
-
NextGen - Clinical Implication of Next Generation Sequencing
RECRUITING · Phase 4
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
-
Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study
RECRUITING
-
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.